Fareeda Y. Coxon
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: April 26, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.
Journal: The Lancet. Oncology
Published: October 06, 2016
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Journal: The Lancet. Oncology
Published: August 31, 2016
Rapid diagnostic pathways for suspected colorectal cancer: views of primary and secondary care clinicians on challenges and their potential solutions.
Journal: BMJ open
Published: October 24, 2015
A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.
Journal: BMC research notes
Published: June 03, 2015
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: June 24, 2014
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial.
Journal: The Lancet. Oncology
Published: December 17, 2013
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.
Journal: The Lancet. Oncology
Published: April 19, 2013
Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 16, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 31, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026